248 related articles for article (PubMed ID: 22830208)
1. [Immunological disorders and cytokine profile in systemic and localized sclerosis].
Ter Arkh; 2012; 84(5):28-31. PubMed ID: 22830208
[TBL] [Abstract][Full Text] [Related]
2. [Comparative characteristics of immunological tests in differentiation of systemic and cutaneous forms of lupus erythematosus].
Romanova NV; Shilkina NP
Ter Arkh; 2009; 81(4):40-3. PubMed ID: 19514420
[TBL] [Abstract][Full Text] [Related]
3. [The immune status of scleroderma patients undergoing electroacupuncture].
Glavinskaia TA; Rezaĭkina AV; Smirnova AV
Vestn Dermatol Venerol; 1989; (4):44-7. PubMed ID: 2788340
[TBL] [Abstract][Full Text] [Related]
4. The involvement of immunoregulatory T cells in the pathogenesis of lichen sclerosus.
Tchórzewski H; Rotsztejn H; Banasik M; Lewkowicz P; Głowacka E
Med Sci Monit; 2005 Jan; 11(1):CR39-43. PubMed ID: 15614194
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
6. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
7. [Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count].
Witt C; Neuhaus K; Winsel K; Brenke A; Hiepe F; Volk HD
Z Erkr Atmungsorgane; 1991; 176(1):21-9. PubMed ID: 2053369
[TBL] [Abstract][Full Text] [Related]
8. [Immune reactivity and cytokine status in polytrauma].
Mkhoian GG; Ter-Pogosian ZR; Gasparian MG; Dzhagatspanian NG; Karalian ZA; Ovanesian GG
Anesteziol Reanimatol; 2009; (4):60-5. PubMed ID: 19824419
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of T-cell immunity in patients with acute leukemia].
Parovichnikova EN; Gal'tseva IV; Vorob'ev IA; Savchenko VG
Ter Arkh; 2006; 78(7):18-25. PubMed ID: 16944746
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
[TBL] [Abstract][Full Text] [Related]
12. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.
Badea I; Taylor M; Rosenberg A; Foldvari M
Rheumatology (Oxford); 2009 Mar; 48(3):213-21. PubMed ID: 19022832
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
[TBL] [Abstract][Full Text] [Related]
16. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
Butov IuS; Skripkin IuK; Koshevenko IuN
Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
[No Abstract] [Full Text] [Related]
17. [Changes in lymphocyte subsets in bronchoalveolar lavage fluid in patients with systemic sclerosis].
Kopiński P; Nalepa P; Wojas-Pelc A; Janowska E; Gil K
Pol Merkur Lekarski; 2000 Jan; 7(43):18-22. PubMed ID: 10765646
[TBL] [Abstract][Full Text] [Related]
18. [Immunological mechanisms in pathogenesis of coronary atherosclerosis].
Mazurov VI; Stolov SV; Zaraĭskiĭ MI
Ter Arkh; 2005; 77(9):24-8. PubMed ID: 16281484
[TBL] [Abstract][Full Text] [Related]
19. The association of HLA-B8 with visceral disease in systemic sclerosis.
Hughes P; Gelsthorpe K; Doughty RW; Rowell NR; Rosenthal FD; Sneddon IB
Clin Exp Immunol; 1978 Mar; 31(3):351-6. PubMed ID: 306903
[TBL] [Abstract][Full Text] [Related]
20. Localized scleroderma and systemic sclerosis: is there a connection?
Gupta RA; Fiorentino D
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
